Elfabrio wins positive CHMP for every-4-weeks dosing in Fabry, boosting sales outlook and EU milestone potential.
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Peripheral neuropathy has become one of the fastest-growing quality-of-life challenges in 2026, especially among people living with diabetes, ...
Millicom International Cellular has structurally reset its business, delivering stable free cash flow and EBITDA margins. Learn why TIGO stock is a Buy.
Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for ...
First-of-its-kind research suggests that the right diet can improve your skin from the inside out.